CAS: 183619-38-7 - 4-Acetamido-N-(tert-butyl)benzamide
Formula:C13H18N2O2
InChI:InChI=1/C13H18N2O2/c1-9(16)14-11-7-5-10(6-8-11)12(17)15-13(2,3)4/h5-8H,1-4H3,(H,14,16)(H,15,17)
- Synonyms:
- Ren-1189
- Cpi-1189
- 4-(acetylamino)-N-tert-butylbenzamide
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | CPI-1189 REF: AN-AG00AS51CAS: 183619-38-7 | 97% | To inquire | Tue 21 May 24 |
 | 4-Acetamido-N-(tert-butyl)benzamide REF: 10-F981175CAS: 183619-38-7 | 97% | 174.00 €~273.00 € | Wed 22 May 24 |
 | CPI1189 REF: TM-T3561CAS: 183619-38-7 | 99.68% | 59.00 €~917.00 € | Tue 28 May 24 |
 | CPI-1189 REF: 3D-IHA61938CAS: 183619-38-7 | Min. 95% | To inquire | Tue 02 Jul 24 |
Ref: AN-AG00AS51
| 1g | To inquire | |
| 5g | To inquire | |
| 1mg | 119.00 € | |
| 25mg | 117.00 € | |
| 100mg | 156.00 € | |
| 250mg | 266.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
Ref: 10-F981175
| 100mg | 174.00 € | |
| 250mg | 273.00 € |
Estimated delivery in United States, on Wednesday 22 May 2024
CPI1189
CAS:183619-38-7
CPI1189 (REN-1189) is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic …
Formula:
C13H18N2O2
Purity:
99.68%
Color and Shape:
Solid
Molecular weight:
234.29
Ref: TM-T3561
| 5mg | 59.00 € | |
| 10mg | 90.00 € | |
| 25mg | 166.00 € | |
| 50mg | 270.00 € | |
| 100mg | 433.00 € | |
| 500mg | 917.00 € | |
| 1ml*10 (DMSO) | 66.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
CPI-1189
CAS:183619-38-7
CPI-1189 is a novel, potent and selective inhibitor of TNF-α. In vitro studies have shown …
Formula:
C13H18N2O2
Purity:
Min. 95%
Molecular weight:
234.29 g/mol
Ref: 3D-IHA61938
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire | |
| 250mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
